Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000206647 is annotated as a small nucleolar RNA (snoRNA) gene located on chromosome 2 (GRCh38: 10,155,072-10,155,206, reverse strand)[5][9]. SnoRNAs are a class of non-coding RNAs that primarily function in the chemical modification (methylation and pseudouridylation) of other RNAs, especially ribosomal RNAs (rRNAs). They act as guide RNAs, directing biochemical modifications but do not code for proteins, and are not considered typical therapeutic targets such as receptors or enzymes[9][1]. ENSG00000206647 (LOC124906144) is a small nucleolar RNA gene and is not a conventional therapeutic target such as a receptor, enzyme, or transporter[1][5][9]. Its designation as a drug discovery or therapeutic target is incorrect, and there are no known interacting drugs, mechanisms of action, or established safety concerns. It is primarily involved in RNA modification as a non-coding RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA (snoRNA).